Search results
A recently published study has described numerous disease mechanisms that appear to be common across different types of inherited sight loss, suggesting that there is significant potential for drug treatments that could work regardless of the underlying causative gene.
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
We recently received an update on the latest research into Charles Bonnet Syndrome from Dr Jasleen Jolly as part of a Retina UK podcast about visual hallucinations.
Researchers have developed PEDF-based eye drops that show promise in slowing retinal degeneration in mice with retinitis pigmentosa, potentially offering a non-invasive treatment option for preserving vision in the future.
Formal notice of the forthcoming Annual General Meeting in July 2025.
Eye2Gene: new publication describes how AI can predict genetic diagnosis from retinal scans
Financial support for young people attending conference
Tribute to Retina UK founder Lynda Cantor MBE
Catch up on our BBC Lifeline Appeal from November 2025.
People living with sight loss in Scotland are able to benefit from free ferry travel for their companion when travelling with Caledonian MacBrayne (CalMac) Ferries with the NEC+1 card. The ferries operate across Scotland’s islands.
